Mišo Šabovič

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersFood properties (incl. characteristics and health benefits)Structure and dynamics of materialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review.

|Jul 04, 2025
Rosuvastatin Improved LDL Subfractions Profile in a Patient with Type 1 Diabetes Following a Ketogenic Diet: A Case Report.

Miodrag Janić, Mojca Lunder, Andrej Janež

|Nov 27, 2024
Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled Trial.

Miodrag Janić, Andrej Janež, Mišo Šabović

|Feb 25, 2023
Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease.

Jovana Nikolajević, Mišo Šabovič

|May 27, 2022
Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes.

Miodrag Janić, Matej Cankar, Jan Šmid

Pageof 1

Frequent Collaborators

3 joint publications

Miodrag Janić

3 joint publications

Andrej Janež

2 joint publications

Mojca Lunder

2 joint publications

Manfredi Rizzo